Clinical Trials Directory

Trials / Completed

CompletedNCT02418390

The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
101 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The aim of this study is to investigate the efficacy and safety of prophylactic central lymph node dissection in papillary thyroid carcinoma.

Detailed description

The aim of this study is to investigate the efficacy and safety of prophylactic central lymph node dissection in papillary thyroid carcinoma. Primary outcome is the surgical completeness, recurrence rate, and successful ablation rate. Secondary outcomes are the incidence of postoperative complications and PTC stage. The enrolled patients were randomly assigned to control group and intervention group (1:1 allocation).

Conditions

Interventions

TypeNameDescription
PROCEDUREprophylactic central lymph node dissectiondissection of level VI compartment by AAHNS (American association of head and neck surgeons) classification

Timeline

Start date
2015-04-01
Primary completion
2020-10-08
Completion
2020-10-08
First posted
2015-04-16
Last updated
2022-06-01

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02418390. Inclusion in this directory is not an endorsement.

The Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid Carcinoma (NCT02418390) · Clinical Trials Directory